BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 24842984)

  • 1. Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study.
    Eppenga WL; Lalmohamed A; Geerts AF; Derijks HJ; Wensing M; Egberts A; De Smet PA; de Vries F
    Diabetes Care; 2014 Aug; 37(8):2218-24. PubMed ID: 24842984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes.
    Lee EY; Hwang S; Lee YH; Lee SH; Lee YM; Kang HP; Han E; Lee W; Lee BW; Kang ES; Cha BS; Lee HC
    Yonsei Med J; 2017 Mar; 58(2):312-318. PubMed ID: 28120561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactate levels and risk of lactic acidosis with metformin in diabetic kidney disease patients.
    Bipi PK; George J; Gomathy S; Gracious N; Kumar S; Mohandas MK
    Saudi J Kidney Dis Transpl; 2017; 28(6):1356-1361. PubMed ID: 29265047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements.
    van Berlo-van de Laar IR; Vermeij CG; Doorenbos CJ
    J Clin Pharm Ther; 2011 Jun; 36(3):376-82. PubMed ID: 21545617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Japanese regulatory action on metformin-associated lactic acidosis in type II diabetes patients.
    Hanatani T; Sai K; Tohkin M; Segawa K; Saito Y
    Int J Clin Pharm; 2015 Jun; 37(3):537-45. PubMed ID: 25822043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease.
    Sipahi S; Solak Y; Acikgoz SB; Genc AB; Yildirim M; Yilmaz U; Nalbant A; Tamer A
    Int Urol Nephrol; 2016 Aug; 48(8):1305-1312. PubMed ID: 27102431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas.
    Chu PY; Hackstadt AJ; Chipman J; Griffin MR; Hung AM; Greevy RA; Grijalva CG; Elasy T; Roumie CL
    Diabetes Care; 2020 Jul; 43(7):1462-1470. PubMed ID: 32327421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin use and risk of lactic acidosis in people with diabetes with and without renal impairment: a cohort study in Denmark and the UK.
    Li L; Jick S; Gopalakrishnan C; Heide-Jørgensen U; Nørrelund H; Sørensen HT; Christiansen CF; Ehrenstein V
    Diabet Med; 2017 Apr; 34(4):485-489. PubMed ID: 27504911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: A GoDarts study.
    Connelly PJ; Lonergan M; Soto-Pedre E; Donnelly L; Zhou K; Pearson ER
    Diabetes Obes Metab; 2017 Nov; 19(11):1579-1586. PubMed ID: 28432751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin therapy in patients with chronic kidney disease.
    Duong JK; Roberts DM; Furlong TJ; Kumar SS; Greenfield JR; Kirkpatrick CM; Graham GG; Williams KM; Day RO
    Diabetes Obes Metab; 2012 Oct; 14(10):963-5. PubMed ID: 22564555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse event notifications implicating metformin with lactic acidosis in Australia.
    Huang W; Castelino RL; Peterson GM
    J Diabetes Complications; 2015; 29(8):1261-5. PubMed ID: 26104729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study.
    Richy FF; Sabidó-Espin M; Guedes S; Corvino FA; Gottwald-Hostalek U
    Diabetes Care; 2014 Aug; 37(8):2291-5. PubMed ID: 24879835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of lactic acidosis in type 2 diabetes patients using metformin: A case control study.
    Aharaz A; Pottegård A; Henriksen DP; Hallas J; Beck-Nielsen H; Lassen AT
    PLoS One; 2018; 13(5):e0196122. PubMed ID: 29738540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter S; Greyber E; Pasternak G; Salpeter E
    Cochrane Database Syst Rev; 2002; (2):CD002967. PubMed ID: 12076461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of lactic acidosis in type 2 diabetes patients with metformin in Japan.
    Chang CH; Sakaguchi M; Dolin P
    Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1196-1203. PubMed ID: 27221971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study.
    Lazarus B; Wu A; Shin JI; Sang Y; Alexander GC; Secora A; Inker LA; Coresh J; Chang AR; Grams ME
    JAMA Intern Med; 2018 Jul; 178(7):903-910. PubMed ID: 29868840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin-associated lactic acidosis: Current perspectives on causes and risk.
    DeFronzo R; Fleming GA; Chen K; Bicsak TA
    Metabolism; 2016 Feb; 65(2):20-9. PubMed ID: 26773926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis.
    Bodmer M; Meier C; Krähenbühl S; Jick SS; Meier CR
    Diabetes Care; 2008 Nov; 31(11):2086-91. PubMed ID: 18782901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactate Levels with Chronic Metformin Use: A Narrative Review.
    Huang W; Castelino RL; Peterson GM
    Clin Drug Investig; 2017 Nov; 37(11):991-1007. PubMed ID: 28836132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of lactic acidosis in metformin users.
    Stang M; Wysowski DK; Butler-Jones D
    Diabetes Care; 1999 Jun; 22(6):925-7. PubMed ID: 10372243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.